Literature DB >> 3258478

Pattern differences in experimental fevers induced by endotoxin, endogenous pyrogen, and prostaglandins.

A Morimoto1, T Nakamori, T Watanabe, T Ono, N Murakami.   

Abstract

To distinguish pattern differences in experimentally induced fevers, we investigated febrile responses induced by intravenous (IV), intracerebroventricular (ICV), and intra-preoptic/anterior hypothalamic (POA) administration of bacterial endotoxin (lipopolysaccharide, LPS), endogenous pyrogen (EP), human recombinant interleukin-1 alpha (IL-1), and prostaglandins E2 and F2 alpha (PGE2 and PGF2 alpha). Intravenous LPS, EP, or IL-1 in high concentrations caused biphasic fever. In low concentrations, they induced only the first phase of fever. Latency to onset and time to first peak of fever induced by IV injection of LPS or EP were almost the same as those after ICV or POA injection of PGE2. Fever induced by ICV or POA administration of LPS, EP, IL-1, or PGF2 alpha had a long latency to onset and a prolonged time course. There were significant differences among the latencies to fever onset exhibited by groups that received ICV or POA injections of LPS, EP, or PGF2 alpha and by groups given IV injections of LPS or EP and ICV or POA injections of PGE2. Present observations indicate different patterns of fever produced by several kinds of pyrogens when given by various routes. These results permit us to consider the possibility that there are several mediators or multiprocesses underlying the pathogenesis of fever.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258478     DOI: 10.1152/ajpregu.1988.254.4.R633

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Central action sites of interleukin-1 beta for inducing fever in rabbits.

Authors:  N Murakami; Y Sakata; T Watanabe
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

Review 2.  Leptin: at the crossroads of energy balance and systemic inflammation.

Authors:  Alexandre A Steiner; Andrej A Romanovsky
Journal:  Prog Lipid Res       Date:  2006-12-21       Impact factor: 16.195

3.  Evaluation of Analgesic and Antipyretic Activities of Centratherum anthelminticum (L) Kuntze Seed.

Authors:  A Purnima; B C Koti; V P Tikare; A H M Viswanathaswamy; A H M Thippeswamy; P Dabadi
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

4.  Effect of combined administration of a synthetic low-toxicity lipid A derivative, DT-5461a, and indomethacin in various experimental tumor models of colon 26 carcinoma in mice.

Authors:  T Jimbo; T Akimoto; A Tohgo
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

5.  Assessment of pharmacological activities of two medicinal plant of Bangladesh: Launaea sarmentosa and Aegialitis rotundifolia roxb in the management of pain, pyrexia and inflammation.

Authors:  Golam Sarwar Raju; Md Mizanur Rahman Moghal; Mohammad Salim Hossain; Md Mahadi Hassan; Md Mustahsan Billah; Sayed Koushik Ahamed; S M Masud Rana
Journal:  Biol Res       Date:  2014-10-28       Impact factor: 5.612

6.  Antiinflammatory, Analgesic and Antipyretic Activities of Aerial Parts of Costus speciosus Koen.

Authors:  Shruti Srivastava; P Singh; K K Jha; Garima Mishra; S Srivastava; R L Khosa
Journal:  Indian J Pharm Sci       Date:  2013-01       Impact factor: 0.975

7.  Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6.

Authors:  M G De Simoni; M Sironi; A De Luigi; A Manfridi; A Mantovani; P Ghezzi
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

Review 8.  Central mediators involved in the febrile response: effects of antipyretic drugs.

Authors:  Aleksander R Zampronio; Denis M Soares; Glória E P Souza
Journal:  Temperature (Austin)       Date:  2015-10-13

9.  Experimental evaluation of anti-inflammatory, antinociceptive and antipyretic activities of clove oil in mice.

Authors:  Yousef A Taher; Awatef M Samud; Fathy E El-Taher; Ghazala ben-Hussin; Jamal S Elmezogi; Badryia F Al-Mehdawi; Hanan A Salem
Journal:  Libyan J Med       Date:  2015-09-01       Impact factor: 1.743

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.